3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Neoplasms
6
Depression
6
Breast Neoplasms
6
Multiple Myeloma
5
Leukemia
4
Brain Neoplasms
4
Waldenstrom Macroglobulinemia
3
Sezary Syndrome
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Vomiting
2
Nausea
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Interventions
relacorilant
3
Nutrition Assessment
2
ganirelix
1
clevidipine
1
cediranib
1
benazepril
1
aliskiren
1
Vitamin D
1
Therapeutics
1
Surveys and Questionnaires
1
Sulindac
1
Resistance Training
1
Ramipril
1
Observation
1
Methyltestosterone
1
Methods
1
Losartan
1
Lisinopril
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Interviews as Topic
1
Fatty Acids, Omega-3
1
Enalapril
1
Educational Status
1
Desvenlafaxine Succinate
1
Adrenalectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Hypertension
×
Therapeutics
×
Clear all
NCT03443635
2022-04-29
CHOP
Tulane University
Phase 1/2
Completed
7,192 enrolled
7 charts